N0539 phase II trial of fulvestrant and bevacizumab in patients with metastatic breast cancer previously treated with an aromatase inhibitor: a North Central Cancer Treatment Group (now Alliance) trial
- Citation:
- Ann Oncol vol 10 (24) 2548-54
- Year:
- 2013
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 2
- Parents:
- 364
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- W. W. Tan A. C. Dueck P. Flynn P. Steen D. Anderson K. Rowland Jr D. Northfelt E. A. Perez
- Networks:
- Study
- NCCTG-N0539
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: